Investor Relations

Dr Abdul Manaf Bin Mohamad Radzi was appointed to the Board on 10 October 2017 as an Independent Non-Executive Chairman.

He holds a Doctor of Philosophy in Physical Chemistry and minor in Inorganic Chemistry from University of Tennessee, Knoxville, United States of America.

Dr Abdul Manaf Bin Mohamad Radzi started his career in 1977 as a researcher at the chemistry laboratory in Northern Illinois University. In 1988 he joined ICI Fertilizers Sdn Bhd as a Technical Executive and was promoted to Marketing Executive in 1990. In 1992, he joined PETRONAS Petroleum Research Institute (now known as PETRONAS Research & Scientific Services Sdn Bhd) as an Agrochemical Executive. In 1994, he was transferred to the Malaysian International Trading Corporation Sdn Bhd (a subsidiary of PETRONAS Research Sdn Bhd) as a trader for urea and agrochemicals in Vietnam.

In 1995, he joined FRC Manufacturing (M) Sdn Bhd as a Technical Executive. In 1996, he joined ACP Industries Berhad as the Manager for special projects division. In 2004 he joined the education sector and became a lecturer in Sunway College. In 2005, he joined Chemical Company of Malaysia Berhad as the Group Market Development Manager and was promoted to Senior Manager in 2006. In 2007, he was promoted as the General Manager of CCM Duopharma Biotech Berhad (a subsidiary of Chemical Company of Malaysia Berhad).

In 2009, he joined Innovax Sdn Bhd as the Chief Scientific Officer. In 2010, he joined Malaysian Bioeconomy Development as the Senior VicePresident of its Industrial Division. In 2015, he served as the Senior VicePresident of the University-Industry Partnership Division in Malaysian Bioeconomy Development. He also served as a member of the Scientific Advisory Board of Bioalpha Holdings Berhad before retiring in 2017.

Phang Nyie Lin was appointed to the Board on 10 October 2017 as the Group Managing Director.

He holds a Bachelor of Pharmacy from Science University of Malaysia. He started his career as a pharmacist trainee in the pharmacy department of Ipoh General Hospital, Perak (now known as Hospital Raja Permaisuri Bainun). He became a registered pharmacist with the Ministry of Health after he completed his training in 1981. In 1983, he was transferred to the National Tuberculosis Centre (now known as the Department of Respiratory Medicine, Hospital Kuala Lumpur) to serve as a pharmacist. In 1985, he left the National Tuberculosis Centre to set up Farmasi Sepadu, a community pharmacy in Sungai Pelek, Selangor, which was involved in the distribution of animal health products to livestock farms. In 1989, he established Nova Laboratories Sdn Bhd.

As the Group Managing Director, he is responsible for providing the strategic direction and overseeing the overall business operations of our Group. He also holds the position of Chief Research Officer and is responsible for overseeing all R&D activities including conceptualising ideas for new product developments and re-formulation of existing products.

Phang Yeen Nung was appointed to the Board on 10 October 2017 as an Executive Director.

He holds a Bachelor of Laws from University of Kent, United Kingdom. He started his career as a Marketing Executive in Nova Laboratories.

In 2014, he was promoted to Business Development Director and in that capacity was responsible for identifying new business opportunities.

Phang Yeen Aun was appointed to the Board on 10 October 2017 as an Executive Director.

He holds a Bachelor of Pharmacy from International Medical University, Malaysia. He started his career as a pharmacist trainee in the pharmacy department of Hospital Tuanku Ja’afar, Seremban. In 2011, he joined Nova Laboratories as a Marketing Executive and in that capacity was responsible for developing and executing new marketing plans and promotion campaigns for our products and the “NOVA” brand in the industry.

In 2012, he served as the Managing Director of Nutraphyll where he was responsible for providing the strategic direction and overseeing the overall business operations. Nutraphyll owned and operated six retail outlets exclusively selling our House Brand products. Nutraphyll was previously controlled by our Promoters through their shareholdings and directorships in Nutraphyll until August 2017.

In 2017, he left Nutraphyll and joined our Group as the Executive Director

Sulaiman Bin Haji Ahmad was appointed to the Board on 10 October 2017 as the Non Independent Non-Executive Director.

He holds a Bachelor of Pharmacy from the Science University of Malaysia. He became a registered pharmacist with the Ministry of Health after he completed his training in 1982. He started his career as a pharmacist in the manufacturing unit of the Sabah Central Medical Store and Hospital Queen Elizabeth, Sabah in 1982. In 1985, he was transferred to the National Pharmaceutical Control Bureau (now known as National Pharmaceutical Regulatory Agency) as an Analytical Pharmacist responsible for product analysis.

In 1990, he was promoted to Senior Pharmacist and was subsequently transferred to the GMP division of the National Pharmaceutical Control Bureau as a GMP Auditor responsible for conducting GMP audits. In 2005, he was promoted to Head of Department of Compliance and Licensing for the GMP division until 2008.

In 2008, he was transferred to Hospital Klang, Selangor as Chief Pharmacist and the Head of its pharmacy department. In 2009, he was transferred to Hospital Raja Permaisuri Bainun, Perak as Chief Pharmacist and the Head of its pharmacy department. In 2010, he was promoted and transferred back to National Pharmaceutical Control Bureau as Deputy Director to lead its GMP and licensing division. He retired from his role as Deputy Director in 2016.

Sim Seng Loong @ Tai Seng was appointed to the Board on 10 October 2017 as an Independent NonExecutive Director. He is the Chairman of the Audit Committee and Risk Management Committee, and a member of the Remuneration and Nomination Committees.

He is a chartered accountant and has been a member of Malaysian Institute of Certified Public Accountants (“MICPA”) (previously known as Malaysian Association of Certified Public Accountants) since May 1994, Malaysian Institute of Accountants since March 1995 and Certified Practising Accountant Australia since March 2008.

He started his career as an Auditor with a big four accounting firm from 1988 until 2004. In 2004, he admitted as a Partner of an accounting firm, R.K. & Associates. In 2007, he joined Eaton Industries Pty. Ltd. (Australia) as a Corporate Accountant where he was tasked to coordinate the company’s world-wide restructuring exercise. He was transferred to Shanghai Eaton Engine Components Ltd, China in 2009 as a Financial Controller. He joined The BIG Group Sdn Bhd in January 2012 as Chief Financial Officer and Chief Operating Officer before leaving in 2013. During his time at The BIG Group Sdn Bhd, he was primarily responsible for the finance and information technology functions of the company and day-to-day operations which also includes new restaurant openings. In 2013, he was appointed as the Chief Financial Officer of Petrol One Resources Berhad. In 2019, he left Petrol One Resources Berhad and joined Silverpack Sdn Bhd as the Chief Financial Officer, a position he assumes to present.

Over the years, he has accumulated extensive experience not only in supervising financial audit and reporting accountant projects for corporate exercises like mergers, acquisitions and IPO, he also oversees overall finance function and daily business operations as well as leading and coordinating worldwide restructuring exercise as Chief Financial Officer.

Directorship in other public companies and listed issuers:

• Pentamaster International Limited (Independent Non-Executive Director)
• Ramssol Group Berhad (Independent Non-Executive Director)

Tan Mio Har was appointed to the Board on 10 October 2017 as an Independent Non-Executive Director.

She holds a Diploma in Business Studies in Accounting from Tunku Abdul Rahman College, Malaysia. She has been a member of the Association of Chartered Certified Accountants since 2011 and she was admitted as a fellow of Association of Chartered Certified Accountants in May 2016. She has also been a member of the Malaysian Institute of Accountants since 2016.

She started her career as an Auditor with Adrian Yeo & Co in 2007 where she performed auditing work on companies in various industries. In 2009, she left the company to join Palm Gold Corporation Sdn Bhd as an Internal Audit Executive where she performed risk-based internal audits and reviewed the suitability and compliance of the company’s internal control policies and procedures.

In 2012, she left Palm Gold Corporation Sdn Bhd and joined ST Rock Blasting Sdn Bhd as an Accountant where her responsibilities include handling financial accounts and taxation matters as well as preparing analytical reviews of the company’s finance operations, a position she still holds.

Mr Cheong holds a Bachelor of Arts in Marketing from University of Northumbria, New castle, United Kingdom.

He started his career as a Sales Representative with Hovid Pharmacy Sdn Bhd in 2004 promoting generic products. In 2005, he joined Nova Laboratories as a Sales representative. He was promoted to Sales Manager in 2007. He continued expanding his career in the company by developing his skills and knowledge in sales and marketing.

He was promoted as the Group’s Chief Business Officer in 2015 where he oversees the sales and marketing division for local markets.

Ms Sangeetha holds a Bachelor of Science in Biotechnology from Tunku Abdul Rahman University, Malaysia.

She started her career as a Regulatory Executive in Nova Laboratories in 2006. She was promoted to Regulatory and Quality Assurance Manager in 2008 and as Choef Quality Officer in 2016. She continued expanding her career in the company by developing her skills and knowledge in regulatory affairs, GMP, and HALAL matters and has 15 years of exprienece in these areas.

She was promoted as the Group’s Chief Compliance Officer in 2019 where she oversees the regulatory affairs and compliance division of the Group.

Mr Tan holds a Bachelor of Pharmacy from Cyberjaya University College of Medical Sciences, Malaysia.

He started his career as a trainee pharmacist in Y.S.P Industries (M) Sdn Bhd in 2012. In 2014, he joined Nova Laboratories as a Marketing Manager. He was promoted to the Group’s Chief Production Officer in 2016 where he oversees the manufacturing division of the Group.

Chow Siew Meng has been a member of the Association of Chartered Certified Accountants since 1996 and was admitted as a fellow member in 2001. He has also been a member of the Malaysian Institute of Accountants and Chartered Tax Institute of Malaysia since 1997 and 2001 respectively.

He has more than 15 years of experience in the areas of financial reporting, tax advisory, and liquidation. Prior to joining the Group as a Chief Financial Officer in 2019, he was attached to a company listed on the Main Market of Bursa Securities as the Chief Financial Controller where he served for three years.